Back

New developments in P2Y12 blockade

20 October 2022 (15:15 - 15:37)
Organised by: Logo
Seminar Presentation Part of: New avenues for combating atherothrombosis Thrombosis, Bleeding Open Access EuroThrombosis and EuroVessels 2022 WG on Thrombosis

About the speaker

Photo
Professor Robert Storey

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
The era of personalized medicine on antithrombotics
Professor C. Patrono (Rome, IT)
Presentation thumbnail
LDL-cholesterol and beyond
Doctor C. Aguiar (Lisbon, PT)
Presentation thumbnail
Repurposing old drugs targeting inflammation
Associate Professor B. Gigante (Stockholm, SE)

Access the full session

Session thumbnail
New avenues for combating atherothrombosis

The Event

Event poster

EuroThrombosis and EuroVessels 2022

20 October 2022 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients
1 September 2019
thumbnail
Congress Session
The new frontier in oral anticoagulation: Factor XIa inhibitors
16 April 2023
thumbnail
Congress Presentation
Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.
2 September 2019
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources